Published in J Chem Phys on October 28, 2013
Docking Screens for Novel Ligands Conferring New Biology. J Med Chem (2016) 0.90
Dynamics of lipids, cholesterol, and transmembrane α-helices from microsecond molecular dynamics simulations. J Phys Chem B (2014) 0.78
EGFR oligomerization organizes kinase-active dimers into competent signalling platforms. Nat Commun (2016) 0.78
Allosteric Communication Disrupted by a Small Molecule Binding to the Imidazole Glycerol Phosphate Synthase Protein-Protein Interface. Biochemistry (2016) 0.77
Lowered pH Leads to Fusion Peptide Release and a Highly Dynamic Intermediate of Influenza Hemagglutinin. J Phys Chem B (2016) 0.77
Network representation of conformational transitions between hidden intermediates of Rd-apocytochrome b562. J Chem Phys (2015) 0.77
Pore Structure and Synergy in Antimicrobial Peptides of the Magainin Family. PLoS Comput Biol (2016) 0.76
Disulfide Bridges: Bringing Together Frustrated Structure in a Bioactive Peptide. Biophys J (2016) 0.75
A Stochastic Algorithm for the Isobaric-Isothermal Ensemble with Ewald Summations for All Long Range Forces. J Chem Theory Comput (2015) 0.75
Capturing Invisible Motions in the Transition from Ground to Rare Excited States of T4 Lysozyme L99A. Biophys J (2016) 0.75
Atomistic Modeling of Ion Conduction Through the Voltage-Sensing Domain of the Shaker K(+) Ion Channel. J Phys Chem B (2017) 0.75
Glide: a new approach for rapid, accurate docking and scoring. 1. Method and assessment of docking accuracy. J Med Chem (2004) 15.51
Improved side-chain torsion potentials for the Amber ff99SB protein force field. Proteins (2010) 9.43
Atomic-level characterization of the structural dynamics of proteins. Science (2010) 8.36
How fast-folding proteins fold. Science (2011) 6.24
Structure and function of an irreversible agonist-β(2) adrenoceptor complex. Nature (2011) 5.35
A hierarchical approach to all-atom protein loop prediction. Proteins (2004) 5.18
The dynamic process of β(2)-adrenergic receptor activation. Cell (2013) 4.09
Structure and dynamics of the M3 muscarinic acetylcholine receptor. Nature (2012) 3.83
Long-timescale molecular dynamics simulations of protein structure and function. Curr Opin Struct Biol (2009) 3.81
Mechanism of voltage gating in potassium channels. Science (2012) 3.24
How robust are protein folding simulations with respect to force field parameterization? Biophys J (2011) 3.00
Biomolecular simulation: a computational microscope for molecular biology. Annu Rev Biophys (2012) 2.85
Identification of two distinct inactive conformations of the beta2-adrenergic receptor reconciles structural and biochemical observations. Proc Natl Acad Sci U S A (2009) 2.77
Oncogenic mutations counteract intrinsic disorder in the EGFR kinase and promote receptor dimerization. Cell (2012) 2.67
Structural analysis of the catalytically inactive kinase domain of the human EGF receptor 3. Proc Natl Acad Sci U S A (2009) 2.55
Activation mechanism of the β2-adrenergic receptor. Proc Natl Acad Sci U S A (2011) 2.53
PHASE: a new engine for pharmacophore perception, 3D QSAR model development, and 3D database screening: 1. Methodology and preliminary results. J Comput Aided Mol Des (2006) 2.53
Conformational coupling across the plasma membrane in activation of the EGF receptor. Cell (2013) 2.49
Principles of conduction and hydrophobic gating in K+ channels. Proc Natl Acad Sci U S A (2010) 2.47
Pathway and mechanism of drug binding to G-protein-coupled receptors. Proc Natl Acad Sci U S A (2011) 2.44
High-resolution crystal structure of human protease-activated receptor 1. Nature (2012) 2.44
Water in protein structure prediction. Proc Natl Acad Sci U S A (2004) 2.35
Gaussian split Ewald: A fast Ewald mesh method for molecular simulation. J Chem Phys (2005) 2.32
Architecture and membrane interactions of the EGF receptor. Cell (2013) 2.29
Systematic validation of protein force fields against experimental data. PLoS One (2012) 2.29
A conserved protonation-dependent switch controls drug binding in the Abl kinase. Proc Natl Acad Sci U S A (2008) 2.18
Real-world illumination and the perception of surface reflectance properties. J Vis (2003) 2.17
How does a drug molecule find its target binding site? J Am Chem Soc (2011) 2.13
Microsecond molecular dynamics simulation shows effect of slow loop dynamics on backbone amide order parameters of proteins. J Phys Chem B (2008) 1.90
Structure of human urokinase plasminogen activator in complex with its receptor. Science (2006) 1.84
Mechanism of Na+/H+ antiporting. Science (2007) 1.79
Preconfiguration of the antigen-binding site during affinity maturation of a broadly neutralizing influenza virus antibody. Proc Natl Acad Sci U S A (2012) 1.70
Atomic-level description of ubiquitin folding. Proc Natl Acad Sci U S A (2013) 1.65
Equally potent inhibition of c-Src and Abl by compounds that recognize inactive kinase conformations. Cancer Res (2009) 1.64
Structural basis for modulation of a G-protein-coupled receptor by allosteric drugs. Nature (2013) 1.59
Superoxide dismutase 1 (SOD1) is essential for H2O2-mediated oxidation and inactivation of phosphatases in growth factor signaling. Proc Natl Acad Sci U S A (2008) 1.58
Copper binding by tetrathiomolybdate attenuates angiogenesis and tumor cell proliferation through the inhibition of superoxide dismutase 1. Clin Cancer Res (2006) 1.58
Refinement of protein structure homology models via long, all-atom molecular dynamics simulations. Proteins (2012) 1.52
The role of ligands on the equilibria between functional states of a G protein-coupled receptor. J Am Chem Soc (2013) 1.48
Computational design and experimental testing of the fastest-folding β-sheet protein. J Mol Biol (2010) 1.46
Structure and dynamics of an unfolded protein examined by molecular dynamics simulation. J Am Chem Soc (2012) 1.46
Protein folding kinetics and thermodynamics from atomistic simulation. Proc Natl Acad Sci U S A (2012) 1.46
Exploring atomic resolution physiology on a femtosecond to millisecond timescale using molecular dynamics simulations. J Gen Physiol (2010) 1.44
A common, avoidable source of error in molecular dynamics integrators. J Chem Phys (2007) 1.34
Transitions to catalytically inactive conformations in EGFR kinase. Proc Natl Acad Sci U S A (2013) 1.34
Dynamic control of slow water transport by aquaporin 0: implications for hydration and junction stability in the eye lens. Proc Natl Acad Sci U S A (2008) 1.30
A non-RGD-based integrin binding peptide (ATN-161) blocks breast cancer growth and metastasis in vivo. Mol Cancer Ther (2006) 1.29
The midpoint method for parallelization of particle simulations. J Chem Phys (2006) 1.27
Angiogenesis blockade as a new therapeutic approach to experimental colitis. Gut (2006) 1.26
Crystal structures of the JAK2 pseudokinase domain and the pathogenic mutant V617F. Nat Struct Mol Biol (2012) 1.25
Structural basis of interaction between urokinase-type plasminogen activator and its receptor. J Mol Biol (2006) 1.25
Folding funnels: the key to robust protein structure prediction. J Comput Chem (2002) 1.25
Crystal structures of two human vitronectin, urokinase and urokinase receptor complexes. Nat Struct Mol Biol (2008) 1.23
Molecular determinants of drug-receptor binding kinetics. Drug Discov Today (2013) 1.17
In support of the BMRB. Nat Struct Mol Biol (2012) 1.09
Associative memory Hamiltonians for structure prediction without homology: alpha/beta proteins. Proc Natl Acad Sci U S A (2003) 1.06
The future of molecular dynamics simulations in drug discovery. J Comput Aided Mol Des (2011) 1.06
Atomic-level simulation of current-voltage relationships in single-file ion channels. J Gen Physiol (2013) 1.06
Targeting the urokinase plasminogen activator receptor inhibits ovarian cancer metastasis. Clin Cancer Res (2010) 1.04
An anti-urokinase plasminogen activator receptor antibody (ATN-658) blocks prostate cancer invasion, migration, growth, and experimental skeletal metastasis in vitro and in vivo. Neoplasia (2010) 1.03
Regulation of RAS oncogenicity by acetylation. Proc Natl Acad Sci U S A (2012) 1.02
Pharmacology of the novel antiangiogenic peptide ATN-161 (Ac-PHSCN-NH2): observation of a U-shaped dose-response curve in several preclinical models of angiogenesis and tumor growth. Clin Cancer Res (2008) 0.93
Evaluating the effects of cutoffs and treatment of long-range electrostatics in protein folding simulations. PLoS One (2012) 0.92